Stay updated on Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.
Latest updates to the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated to version 2.14.2 on January 27, 2025, following the removal of version 2.14.1 on November 19, 2024.SummaryDifference1%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check53 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check74 days agoChange DetectedA new addition was made on November 19, 2024, while several important links and a detailed data download section were removed on September 19, 2024.SummaryDifference14%
Stay in the know with updates to Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab Combo vs Pembrolizumab in Melanoma Clinical Trial page.